Arthur J. Shannon | Valeant Pharmaceuticals International, Inc. |
Joseph C. Papa | Valeant Pharmaceuticals International, Inc. |
Paul S. Herendeen | Valeant Pharmaceuticals International, Inc. |
Gregg Gilbert | Deutsche Bank Securities, Inc. |
Umer Raffat | Evercore Group LLC |
David R. Risinger | Morgan Stanley & Co. LLC |
Louise Chen | Cantor Fitzgerald Securities |
Chris Z. Neyor | JPMorgan Securities LLC |
Gary Nachman | BMO Capital Markets (United States) |
Good morning. My name is Amy, and I will be your conference operator today. At this time, I would like to welcome everyone to the Valeant's Fourth Quarter and Full Year 2017 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.